SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
…, S Bogers, G den Hartog, L Gommers… - Science …, 2021 - science.org
The emergence of SARS-CoV-2 variants harboring mutations in the spike (S) protein has
raised concern about potential immune escape. Here, we studied humoral and cellular …
raised concern about potential immune escape. Here, we studied humoral and cellular …
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
…, MM Lamers, S Bogers, S Scherbeijn, L Gommers… - Science …, 2022 - science.org
The severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …
[HTML][HTML] Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA …
…, P Bouwmans, MAGJ ten Dam, L Gommers… - The Lancet Infectious …, 2023 - thelancet.com
Background An urgent need exists to improve the suboptimal COVID-19 vaccine response
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
[HTML][HTML] Immunogenicity of bivalent omicron (BA. 1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON) …
…, S Bogers, LLA van Dijk, L Gommers… - The Lancet Infectious …, 2023 - thelancet.com
Background Bivalent mRNA-based COVID-19 vaccines encoding the ancestral and omicron
spike (S) protein were developed as a countermeasure against antigenically distinct SARS-…
spike (S) protein were developed as a countermeasure against antigenically distinct SARS-…
[HTML][HTML] Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
…, ECM van Gorp, F de Wilt, S Bogers, L Gommers… - Journal of Allergy and …, 2022 - Elsevier
Background Patients with inborn errors of immunity (IEI) are at increased risk of severe
coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore of …
coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore of …
Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people with HIV with hyporesponse after primary vaccination
…, S Bogers, L Gommers… - The Journal of …, 2023 - academic.oup.com
Background The COVIH study is a prospective coronavirus disease 2019 (COVID-19)
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody levels …
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody levels …
[HTML][HTML] Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses
…, SRK Malahe, WJR Rietdijk, M Dieterich, L Gommers… - npj Vaccines, 2023 - nature.com
Cytokines are regulators of the immune response against severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2). However, the contribution of cytokine-secreting CD4 + and …
coronavirus-2 (SARS-CoV-2). However, the contribution of cytokine-secreting CD4 + and …
[HTML][HTML] The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients
…, MH Hemmelder, MAGJ ten Dam, L Gommers… - American Journal of …, 2023 - Elsevier
T-cell–mediated help to B cells is required for the development of humoral responses, in
which the cytokine interleukin (IL)-21 is key. Here, we studied the mRNA-1273 vaccine–induced …
which the cytokine interleukin (IL)-21 is key. Here, we studied the mRNA-1273 vaccine–induced …
[PDF][PDF] Ad26. COV2. S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination
…, NA Kootstra, WJR Rietdijk, KS Schmitz, L Gommers… - Iscience, 2023 - cell.com
The emergence of novel SARS-CoV-2 variants led to the recommendation of booster
vaccinations after Ad26.COV2.S priming. It was previously shown that heterologous booster …
vaccinations after Ad26.COV2.S priming. It was previously shown that heterologous booster …
[HTML][HTML] Repurposing an in vitro measles virus dissemination assay for screening of antiviral compounds
KS Schmitz, MV Lange, L Gommers, K Handrejk… - Viruses, 2022 - mdpi.com
Measles virus (MV) is a highly contagious respiratory virus responsible for outbreaks associated
with significant morbidity and mortality among children and young adults. Although safe …
with significant morbidity and mortality among children and young adults. Although safe …